Logo image of PFNX

Pfenex Inc (PFNX) Stock Price, Quote, News and Overview

NYSEARCA:PFNX - NYSE Arca -

12.75  -0.01 (-0.08%)

After market: 12.75 0 (0%)

PFNX Quote, Performance and Key Statistics

Pfenex Inc

NYSEARCA:PFNX (9/30/2020, 8:04:01 PM)

After market: 12.75 0 (0%)

12.75

-0.01 (-0.08%)

Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
Statistics
52 Week High14
52 Week Low5.26
Market Cap437.29M
Shares34.30M
Float15.74M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PE30.36
Earnings (Next)N/A N/A
IPON/A N/A


PFNX short term performance overview.The bars show the price performance of PFNX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 10 20 30 40 50

PFNX long term performance overview.The bars show the price performance of PFNX in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60

The current stock price of PFNX is 12.75 null. In the past month the price increased by 1.03%. In the past year, price increased by 70.91%.

Pfenex Inc / PFNX Daily stock chart

About PFNX

Company Profile

Pfenex Inc. is a clinical-stage biotechnology company developing and commercializing proteins. The company's lead product candidate is PF582, a biosimilar candidate to Lucentis, for the potential treatment of patients with retinal diseases. It leverages its Pf'nex Expression Technology (TM) platform to build a pipeline of product candidates and preclinical products under development including other biosimilars, as well as vaccines, generics and next generation biologics. Pfenex Inc. is headquartered in San Diego, California.

Company Info

Pfenex Inc

10790 ROSELLE STREET

SAN DIEGO CA 92121

CEO: Evert B. Schimmelpennink

Phone: 858-352-4400

Pfenex Inc / PFNX FAQ

What is the stock price of Pfenex Inc today?

The current stock price of PFNX is 12.75 null. The price decreased by -0.08% in the last trading session.


What is the ticker symbol for Pfenex Inc stock?

The exchange symbol of Pfenex Inc is PFNX and it is listed on the NYSE Arca exchange.


On which exchange is PFNX stock listed?

PFNX stock is listed on the NYSE Arca exchange.


What is Pfenex Inc worth?

Pfenex Inc (PFNX) has a market capitalization of 437.29M null. This makes PFNX a Small Cap stock.


What are the support and resistance levels for Pfenex Inc (PFNX) stock?

Pfenex Inc (PFNX) has a support level at 12.74 and a resistance level at 12.89. Check the full technical report for a detailed analysis of PFNX support and resistance levels.


Should I buy Pfenex Inc (PFNX) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does Pfenex Inc (PFNX) stock pay dividends?

PFNX does not pay a dividend.


What is the Price/Earnings (PE) ratio of Pfenex Inc (PFNX)?

Pfenex Inc (PFNX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.23).


PFNX Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to PFNX. When comparing the yearly performance of all stocks, PFNX is one of the better performing stocks in the market, outperforming 93.5% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

PFNX Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to PFNX. PFNX has an excellent financial health rating, but there are some minor concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PFNX Financial Highlights

Over the last trailing twelve months PFNX reported a non-GAAP Earnings per Share(EPS) of -0.23. The EPS increased by 75% compared to the year before.


Industry RankSector Rank
PM (TTM) -14.1%
ROA -6.76%
ROE N/A
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-25%
Sales Q2Q%-72.22%
EPS 1Y (TTM)75%
Revenue 1Y (TTM)133.69%

PFNX Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 68% to PFNX. The Buy consensus is the average rating of analysts ratings from 5 analysts.


Ownership
Inst Owners0.19%
Ins Owners98.7%
Short Float %N/A
Short RatioN/A
Analysts
Analysts68
Price TargetN/A
EPS Next Y-2833.33%
Revenue Next YearN/A